Grimes & Company’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-563
| Closed | -$4.84K | – | 422 |
|
|
2025
Q1 | $4.84K | Sell |
563
-37
| -6% | -$318 | ﹤0.01% | 368 |
|
|
2024
Q4 | $21.4K | Hold |
600
| – | – | ﹤0.01% | 380 |
|
|
2024
Q3 | $28.3K | Hold |
600
| – | – | ﹤0.01% | 362 |
|
|
2024
Q2 | $30.1K | Sell |
600
-14
| -2% | -$703 | ﹤0.01% | 344 |
|
|
2024
Q1 | $68.8K | Sell |
614
-12
| -2% | -$1.34K | ﹤0.01% | 334 |
|
|
2023
Q4 | $36.3K | Sell |
626
-19
| -3% | -$1.1K | ﹤0.01% | 324 |
|
|
2023
Q3 | $20.5K | Buy |
645
+15
| +2% | +$477 | ﹤0.01% | 300 |
|
|
2023
Q2 | $51.8K | Buy |
630
+6
| +1% | +$493 | ﹤0.01% | 301 |
|
|
2023
Q1 | $64.1K | Buy |
624
+13
| +2% | +$1.34K | ﹤0.01% | 290 |
|
|
2022
Q4 | $89.5K | Buy |
611
+4
| +0.7% | +$586 | ﹤0.01% | 279 |
|
|
2022
Q3 | $103K | Buy |
607
+10
| +2% | +$1.7K | 0.01% | 264 |
|
|
2022
Q2 | $69K | Buy |
597
+22
| +4% | +$2.54K | ﹤0.01% | 268 |
|
|
2022
Q1 | $57K | Buy |
+575
| New | +$57K | ﹤0.01% | 296 |
|